KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

CareDx (CDNA) Non Operating Income (2016 - 2025)

Historic Non Operating Income for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $1.9 million.

  • CareDx's Non Operating Income fell 4196.1% to $1.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $10.9 million, marking a year-over-year decrease of 1800.08%. This contributed to the annual value of $12.1 million for FY2024, which is 851.74% down from last year.
  • As of Q3 2025, CareDx's Non Operating Income stood at $1.9 million, which was down 4196.1% from $2.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Non Operating Income registered a high of $5.2 million during Q3 2023, and its lowest value of -$3.4 million during Q3 2021.
  • Moreover, its 5-year median value for Non Operating Income was $2.4 million (2025), whereas its average is $1.4 million.
  • In the last 5 years, CareDx's Non Operating Income tumbled by 125433.07% in 2021 and then surged by 68230.88% in 2023.
  • Quarter analysis of 5 years shows CareDx's Non Operating Income stood at -$1.7 million in 2021, then skyrocketed by 46.34% to -$924000.0 in 2022, then surged by 608.66% to $4.7 million in 2023, then fell by 25.77% to $3.5 million in 2024, then crashed by 45.37% to $1.9 million in 2025.
  • Its last three reported values are $1.9 million in Q3 2025, $2.4 million for Q2 2025, and $3.1 million during Q1 2025.